[HTML][HTML] Biologic features and treatment outcome of secondary acute lymphoblastic leukemia—a review of 101 cases

R Shivakumar, W Tan, GE Wilding, ES Wang… - Annals of oncology, 2008 - Elsevier
Background Secondary acute lymphoblastic leukemia (sALL) is a rare disease and its
biologic features are not well characterized. Patients and methods We describe a cohort of …

Biologic features and treatment outcome of secondary acute lymphoblastic leukemia—a review of 101 cases

R Shivakumar, W Tan, GE Wilding, ES Wang… - Annals of …, 2008 - ncbi.nlm.nih.gov
Background: Secondary acute lymphoblastic leukemia (sALL) is a rare disease and its
biologic features are not well characterized. Patients and methods: We describe a cohort of …

[引用][C] Biologic features and treatment outcome of secondary acute lymphoblastic leukemia—a review of 101 cases

R Shivakumar, W Tan, GE Wilding, ES Wang… - Annals of …, 2008 - cir.nii.ac.jp
Biologic features and treatment outcome of secondary acute lymphoblastic leukemia—a review
of 101 cases | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …

[PDF][PDF] Biologic features and treatment outcome of secondary acute lymphoblastic leukemia—a review of 101 cases

R Shivakumar, W Tan, GE Wilding, ES Wang… - Annals of …, 2008 - researchgate.net
Background: Secondary acute lymphoblastic leukemia (sALL) is a rare disease and its
biologic features are not well characterized. Patients and methods: We describe a cohort of …

Biologic features and treatment outcome of secondary acute lymphoblastic leukemia--a review of 101 cases.

R Shivakumar, W Tan, GE Wilding… - Annals of Oncology …, 2008 - europepmc.org
original article Page 1 Annals of Oncology 19: 1634–1638, 2008 doi:10.1093/annonc/mdn182
Published online 7 May 2008 original article Biologic features and treatment outcome of …

Biologic features and treatment outcome of secondary acute lymphoblastic leukemia—a review of 101 cases

R Shivakumar, W Tan, GE Wilding… - Annals of …, 2008 - annalsofoncology.org
Background Secondary acute lymphoblastic leukemia (sALL) is a rare disease and its
biologic features are not well characterized. Patients and methods We describe a cohort of …

[引用][C] Biologic features and treatment outcome of secondary acute lymphoblastic leukemia-a review of 101 cases

R SHIVAKUMAR, W TAN, GE WILDING… - Annals of …, 2008 - pascal-francis.inist.fr
Biologic features and treatment outcome of secondary acute lymphoblastic leukemia-a
review of 101 cases CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

[PDF][PDF] Biologic features and treatment outcome of secondary acute lymphoblastic leukemia—a review of 101 cases

R Shivakumar, W Tan, GE Wilding, ES Wang… - 2008 - academia.edu
Background: Secondary acute lymphoblastic leukemia (sALL) is a rare disease and its
biologic features are not well characterized. Patients and methods: We describe a cohort of …

Biologic features and treatment outcome of secondary acute lymphoblastic leukemia--a review of 101 cases

R Shivakumar, W Tan, GE Wilding… - Annals of oncology …, 2008 - pubmed.ncbi.nlm.nih.gov
Background Secondary acute lymphoblastic leukemia (sALL) is a rare disease and its
biologic features are not well characterized. Patients and methods We describe a cohort of …

Biologic features and treatment outcome of secondary acute lymphoblastic leukemia--a review of 101 cases.

R Shivakumar, W Tan, GE Wilding… - Annals of Oncology …, 2008 - europepmc.org
Biologic features and treatment outcome of secondary acute lymphoblastic leukemia--a review
of 101 cases. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …